Ledger.Open graph →
SEC Form D · filed August 22, 2019

Harmony Biosciences II, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PLYMOUTH MEETING, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Octagon Bech Capital Group, LLC · Millburn, NJPromoterJohn Jacobs · Downers Grove, ILExec · DirectorJeffrey Aronin · Northbrook, ILDirectorPatrick Morris · Northbrook, ILExecJack B. Nielsen · PLYMOUTH MEETING, PADirectorMartin B. Edwards · PLYMOUTH MEETING, PADirectorAaron B. Royston · PLYMOUTH MEETING, PADirectorDr. Andreas B. Wicki · PLYMOUTH MEETING, PADirectorWilbur B. Gantz, Iii · PLYMOUTH MEETING, PADirectorOctagon Bech Capital Group, LLC · Millburn, NJPromoterJuan Sabater · PLYMOUTH MEETING, PADirectorJohn Jacobs · Queensbury, NYExec · DirectorJohn Vittoria · PLYMOUTH MEETING, PAExecAndrew Serafin · PLYMOUTH MEETING, PAExecJeffrey Aronin · Parsippany, NJDirectorAntonio Gracias · San Carlos, CADirectorPatrick Morris · Parsippany, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗